Samsara Bio Capital, LLC Nkarta, Inc. Transaction History
Samsara Bio Capital, LLC
- $317 Million
- Q1 2024
A detailed history of Samsara Bio Capital, LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Samsara Bio Capital, LLC holds 3,768,035 shares of NKTX stock, worth $22.3 Million. This represents 12.85% of its overall portfolio holdings.
Number of Shares
3,768,035
Previous 2,868,035
31.38%
Holding current value
$22.3 Million
Previous $18.9 Million
115.18%
% of portfolio
12.85%
Previous 6.13%
Shares
5 transactions
Others Institutions Holding NKTX
# of Institutions
121Shares Held
52.8MCall Options Held
145KPut Options Held
114K-
Boxer Capital, LLC San Diego, CA5.61MShares$33.1 Million3.15% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.19MShares$30.7 Million1.16% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.8MShares$22.5 Million0.08% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$21.1 Million2.71% of portfolio
-
Sr One Capital Management, LP3.33MShares$19.7 Million12.13% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $288M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...